Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of EOS884448 Alone, and in Combination with Iberdomide with or Without Dexamethasone, in Participants with Relapsed or Refractory Multiple Myeloma

NCT05289492 is registered in ClinicalTrials.gov with iTeos Therapeutics as lead sponsor.

NCT NCT05289492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05289492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of EOS884448 Alone, and in Combination with Iberdomide with or Without Dexamethasone, in Participants with Relapsed or Refractory Multiple Myeloma
Lead sponsor
iTeos Therapeutics
Phase
Phase 1
Overall status
Terminated
Start date
May 1, 2022
Completion date
November 29, 2023
Enrollment
16 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma